Search research articles
Contact Us
Filters
Showing results (371-380 of 385) with videos related to
Page
of 39
Sort By:
Journal of Psychiatry & Neuroscience : JPN
|
March 7, 2019
The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocols
Glenda M. MacQueen, Stefanie Hassel, Stephen R. Arnott, et al.
The Journal of Clinical Psychiatry
|
March 7, 2019
Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 Report
Sidney H Kennedy, Raymond W Lam, Susan Rotzinger, et al.
The Journal of Clinical Psychiatry
|
August 28, 2025
Artificial Intelligence in Depression-Medication Enhancement (AID-ME): A Cluster Randomized Trial of a Deep-Learning-Enabled Clinical Decision Support System for Personalized Depression Treatment Selection and Management
David Benrimoh, Kate Whitmore, Maud Richard, et al.
Nature Communications
|
August 27, 2024
Plasma proteomics of acute tubular injury
Insa M Schmidt, Aditya L Surapaneni, Runqi Zhao, et al.
Nature Communications
|
May 23, 2017
MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes
Juan Pablo Lopez, Laura M Fiori, Cristiana Cruceanu, et al.
Frontiers in Psychiatry
|
February 24, 2022
Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain Disorders
Anthony L Vaccarino, Derek Beaton, Sandra E Black, et al.
BMC Psychiatry
|
April 17, 2016
Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort
Raymond W Lam, Roumen Milev, Susan Rotzinger, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
February 12, 2025
Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders: Guide de pratique 2024 du Canadian Network for Mood and Anxiety Treatments pour le traitement des troubles de l'humeur, des troubles anxieux et des troubles connexes périnatals
Simone N Vigod, Benicio N Frey, Crystal T Clark, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 27, 2021
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
Andrew S Bomback, Gerald B Appel, Debbie S Gipson, et al.
Biorxiv : the Preprint Server for Biology
|
June 19, 2023
The chromatin landscape of healthy and injured cell types in the human kidney
Debora L Gisch, Michelle Brennan, Blue B Lake, et al.
Page
of 39
Search research articles
Search
Showing results (371-380 of 385) with videos related to
Sort By:
Page
of 39
Journal of Psychiatry & Neuroscience : JPN
|
March 7, 2019
The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocols
Glenda M. MacQueen, Stefanie Hassel, Stephen R. Arnott, et al.
The Journal of Clinical Psychiatry
|
March 7, 2019
Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 Report
Sidney H Kennedy, Raymond W Lam, Susan Rotzinger, et al.
The Journal of Clinical Psychiatry
|
August 28, 2025
Artificial Intelligence in Depression-Medication Enhancement (AID-ME): A Cluster Randomized Trial of a Deep-Learning-Enabled Clinical Decision Support System for Personalized Depression Treatment Selection and Management
David Benrimoh, Kate Whitmore, Maud Richard, et al.
Nature Communications
|
August 27, 2024
Plasma proteomics of acute tubular injury
Insa M Schmidt, Aditya L Surapaneni, Runqi Zhao, et al.
Nature Communications
|
May 23, 2017
MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes
Juan Pablo Lopez, Laura M Fiori, Cristiana Cruceanu, et al.
Frontiers in Psychiatry
|
February 24, 2022
Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain Disorders
Anthony L Vaccarino, Derek Beaton, Sandra E Black, et al.
BMC Psychiatry
|
April 17, 2016
Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort
Raymond W Lam, Roumen Milev, Susan Rotzinger, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
February 12, 2025
Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders: Guide de pratique 2024 du Canadian Network for Mood and Anxiety Treatments pour le traitement des troubles de l'humeur, des troubles anxieux et des troubles connexes périnatals
Simone N Vigod, Benicio N Frey, Crystal T Clark, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 27, 2021
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
Andrew S Bomback, Gerald B Appel, Debbie S Gipson, et al.
Biorxiv : the Preprint Server for Biology
|
June 19, 2023
The chromatin landscape of healthy and injured cell types in the human kidney
Debora L Gisch, Michelle Brennan, Blue B Lake, et al.
Page
of 39